InsidersTradesSigma
SynAct Pharma AB: management transactions · Finland · FIN-FSA
FI:synact-pharma-abSE0008241491FI·FIN-FSAMcap 791M€Healthcare
Browse the full management transaction log of SynAct Pharma AB, a publicly traded company based in Finland. Shares are listed on FI FI, under the oversight of FIN-FSA. Operating in the Healthcare sector, SynAct Pharma AB has published 3 public disclosures. Market capitalisation: €790.7m. The latest transaction was filed on 9 March 2026 (Purchase). Among the most active insiders: Jeppe Øvli Øvlesen. The full history is openly available.
3
Insider Decl.
0
Thresholds
€24,448
3 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
14.12 €
Analyst consensus
2 analystsStrong buy
30.00 €Target 34.65 €(+145%)39.30 €
Income statement
Net income−110.8 M€0.0% margin
Valuation
PER (forward)-18.6x
P/Book4.4x
Beta0.88
Balance sheet & cash
Market cap790.7 M€
Total debt1.2 M€
Free Cash Flow−97.3 M€
Debt / Equity1%
Profitability & ownership
ROE-57.7%
ROA-29.6%
% insiders29.9%
% institutions19.4%
Last declaration on 9 March 2026
Declarations3 total
Executives●Purchase35FIN-FSA
€13,3117,900 shares@ €1.68490.0017% mcap100.0% of flow
Aktie
FI:A003W854-1·
Ideal exit: 30 Nov 2026 (T+270)
Executives●Purchase20FIN-FSA
€4,5102,700 shares@ €1.67050.0006% mcap100.0% of flow
Aktie
FI:A003W815-1·
Ideal exit: 28 Nov 2026 (T+270)
Executives●Purchase24FIN-FSA
€6,6273,529 shares@ €1.87780.0008% mcap100.0% of flow
Aktie
FI:A003V108-1·
Ideal exit: 15 Sept 2026 (T+270)
3 of 3 declarations